Literature DB >> 3605143

Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis.

P E Barré, M Gascon-Barré, J L Meakins, D Goltzman.   

Abstract

Hypercalcemia developed in a patient undergoing long-term hemodialysis, and she was found to have noncaseating granulomas on lymph node biopsy. Hydroxychloroquine was administered as therapy for the hypercalcemia. Over 24 weeks of treatment with the drug, concentrations of calcium and 1,25-dihydroxyvitamin D returned to normal. The results demonstrate the capacity of hydroxychloroquine to inhibit the conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D, and emphasize the efficacy of hydroxychloroquine as an alternate to corticosteroids in the treatment of hypercalcemia of granulomatous disease. Hydroxychloroquine may be preferred when existing skeletal disease, or a predisposition to osteopenia, provides relative contraindications to corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3605143     DOI: 10.1016/0002-9343(87)90237-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 2.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

3.  Use of vitamin D drops leading to kidney failure in a 54-year-old man.

Authors:  Bourne L Auguste; Carmen Avila-Casado; Joanne M Bargman
Journal:  CMAJ       Date:  2019-04-08       Impact factor: 8.262

Review 4.  ASIA syndrome, calcinosis cutis and chronic kidney disease following silicone injections. A case-based review.

Authors:  Giuseppe Barilaro; Claudia Spaziani Testa; Antonella Cacciani; Giuseppe Donato; Mira Dimko; Amalia Mariotti
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

Review 5.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

6.  Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up.

Authors:  Yoland Schoindre; Moez Jallouli; Marie-Laure Tanguy; Pascale Ghillani; Lionel Galicier; Olivier Aumaître; Camille Francès; Véronique Le Guern; Frédéric Lioté; Amar Smail; Nicolas Limal; Laurent Perard; Hélène Desmurs-Clavel; Du Le Thi Huong; Bouchra Asli; Jean-Emmanuel Kahn; Laurent Sailler; Félix Ackermann; Thomas Papo; Karim Sacré; Olivier Fain; Jérôme Stirnemann; Patrice Cacoub; Gaëlle Leroux; Judith Cohen-Bittan; Jean-Sébastien Hulot; Philippe Lechat; Lucile Musset; Jean-Charles Piette; Zahir Amoura; Jean-Claude Souberbielle; Nathalie Costedoat-Chalumeau
Journal:  Lupus Sci Med       Date:  2014-06-07

Review 7.  Exploring the Evidence for an Immunomodulatory Role of Vitamin D in Juvenile and Adult Rheumatic Disease.

Authors:  Jiaqi Zou; Clare Thornton; Emma S Chambers; Elizabeth C Rosser; Coziana Ciurtin
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 8.786

Review 8.  Current and emerging pharmacological treatments for sarcoidosis: a review.

Authors:  Scott H Beegle; Kerry Barba; Romel Gobunsuy; Marc A Judson
Journal:  Drug Des Devel Ther       Date:  2013-04-12       Impact factor: 4.162

9.  Hypercalcemia in a male-to-female transgender patient after body contouring injections: a case report.

Authors:  Koppany Visnyei; Maria Samuel; Laura Heacock; Jose A Cortes
Journal:  J Med Case Rep       Date:  2014-02-26

Review 10.  Sarcoidosis and calcium homeostasis disturbances-Do we know where we stand?

Authors:  Łukasz Gwadera; Adam Jerzy Białas; Mikołaj Aleksander Iwański; Paweł Górski; Wojciech Jerzy Piotrowski
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.